AI-Driven Medicine Could Offer Hope for Snakebite Treatment

A team of researchers at the University of Washington has used artificial intelligence (AI) to design synthetic proteins that neutralise lethal snake venom faster, more effectively, and at a lower cost than traditional anti-venom, according to Nvidia. Led by computational biologist Susana Vazquez Torres in Nobel laureate David Baker’s lab, the team developed these proteins using deep learning models. Their study, published in Nature, demonstrates that AI-designed proteins successfully protected animals from fatal venom toxins in laboratory tests.

• Make Telecom Talk My Trusted Source
• 
• 

Also Read: AI Designed for Speech Recognition Deciphers Earthquake Signals

AI’s Role in Snakebite Treatment

“For over a century, anti-venom production has relied on animal immunisation, requiring thousands of snake milkings and plasma extractions. Torres and her team hope to replace this with AI-driven protein design, compressing years of work into weeks,” Nvidia said in a blog post on February 7, 2025.

Faster, Cheaper, and More Effective

Using Nvidia Ampere architecture and L40 GPUs, and deep learning models like RFdiffusion and ProteinMPNN, the Baker Lab generated millions of potential antitoxin structures ‘in silico,’ or in computer simulations. Instead of screening a vast number of these proteins in a lab, they used AI tools to predict how the designer proteins would interact with snake venom toxins, rapidly homing in on the most promising designs, Nvidia explained.

Also Read: Nvidia and Partners Develop AI Model to Predict Future Glucose Levels in Individuals

The researchers created proteins that bind tightly to deadly three-finger toxins (3FTx), neutralising their effects. Lab tests confirmed their stability, and mouse studies showed an 80-100 percent survival rate after exposure to lethal neurotoxins. Unlike conventional anti-venom, these AI-designed proteins were small, heat-resistant, and easy to manufacture without cold storage.